Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Starts Manufacturing HeliScope; Says First Order 'Approaching'

NEW YORK (GenomeWeb News) — Helicos BioSciences has begun manufacturing its Heliscope genome sequencer at its facility in Cambridge, Mass., the company said this week.
 
The company also said it is “approach[ing] receipt of our first commercial order.” It did not elaborate.
 
The company, which began trading on the Nasdaq exchange late last month, said it is expecting to launch the Heliscope late this year.

A comprehensive version of this article appears in the current issue of In Sequence, a GenomeWeb Daily News sister publication.
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.